Coronavirus envelope protein: current knowledge
By D. Schoeman, Burtram C. Fielding. Virology Journal, 2019
1,780 citations recorded by the source corpus.
Coronaviruses (CoVs) primarily cause enzootic infections in birds and mammals but, in the last few decades, have shown to be capable of infecting humans as well. The outbreak of severe acute respiratory syndrome (SARS) in 2003 and, more recently, Middle-East respiratory syndrome (MERS) has demonstrated the lethality of CoVs when they cross the species barrier and infect humans. A renewed interest in coronaviral research has led to the discovery of several novel human CoVs and since then much progress has been made in understanding the CoV life cycle. The CoV envelope (E) protein is a small, integral membrane protein involved in several aspects of the virus’ life cycle, such as assembly, budding, envelope formation, and pathogenesis. Recent studies have expanded on its structural motifs and topology, its functions as an ion-channelling viroporin, and its interactions with both other CoV proteins and host cell proteins. This review aims to establish the current knowledge on CoV E by highlighting the recent progress that has been made and comparing it to previous knowledge. It also compares E to other viral proteins of a similar nature to speculate the relevance of these new findings. Good progress has been made but much still remains unknown and this review has identified some gaps in the current knowledge and made suggestions for consideration in future research. The most progress has been made on SARS-CoV E, highlighting specific structural requirements for its functions in the CoV life cycle as well as mechanisms behind its pathogenesis. Data shows that E is involved in critical aspects of the viral life cycle and that CoVs lacking E make promising vaccine candidates. The high mortality rate of certain CoVs, along with their ease of transmission, underpins the need for more research into CoV molecular biology which can aid in the production of effective anti-coronaviral agents for both human CoVs and enzootic CoVs.
Subfields: Animal Science and Zoology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/0cf9f507a18a00de76b8bb61a2c5c2b66680dd50
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Animal Science and Zoology
In Infectious Diseases
Citations in the corpus
- Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study (2020, background): “Coronaviruses are single-stranded positive-sense RNA viruses that are known to contain some of the largest viral genomes, up to around 32 kbp in length [1–5].”
- The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2 (2020, background): “[39, 42] M protein is known to promote intracellular homeostasis in a virus via various protein interactions.[42] It consists of a short N-terminal and a long C-terminal.”
- Potential interventions for novel coronavirus in China: A systematic review (2020, background): “syndrome (SARS) in 2002 and Middle East respiratory syndrome (MERS) in 2012 has demonstrated the lethality of coronaviruses when they cross the species barrier and infect humans.(2) SARS‐CoV and MERS‐CoV all belong to the β‐coronavirus family.”
- Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment (2020, background): “This protein is involved in several aspects of the virus life cycle, such as assembly, budding, envelope formation, and pathogenesis (Schoeman & Fielding, 2019) .”
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? (2020, positive): “Since the E protein is the determinant of virulence and mediates the host immune reaction to coronavirus [39,40], it is reasonable to speculate that both viruses elicit a similar immune response.”
- Nervous system involvement after infection with COVID-19 and other coronaviruses (2020, background): “CoV is a positive-sense single-stranded RNA virus, which harbors the largest genome among currently known RNA viruses, with a genome length of about 26–32 kb (Schoeman and Fielding, 2019).”
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response (2020, positive): “Because the protein is bound to RNA, the protein is involved in processes related to the viral genome, the viral replication cycle, and the cellular response of host cells to viral infections [12,13].”
- SARS-CoV-2 invades host cells via a novel route: CD147-spike protein (2020, background): “It has been reported that CoVs are non-segmented positive sense RNA viruses, which primarily cause enzootic infections in birds and mammals and have demonstrated strong lethality in humans [1,2].”